Aggregator
Featured review: Does the type of anaesthesia for recanalisation therapies for acute ischaemic stroke affect patient outcomes?
Featured review: What is the accuracy of different combinations of ultrasound imaging and blood tests to diagnose ovarian cancer in women before and after the menopause?
Inhaliranje antibiotika u liječenju privremenog pogoršanja infekcije pluća kod osoba s cističnom fibrozom
Transplantacija matičnih stanica za liječenje sistemske skleroze
Antiagregacijski lijekovi i antikoagulansi za visoki krvni tlak (hipertenziju)
Školski stomatološki programi unaprjeđenja oralnog zdravlja djece
Kakva je točnost različitih kombinacija ultrazvučnih pregleda i krvnih pretraga za dijagnosticiranje raka jajnika kod žena prije i poslije menopauze?
Featured Review: Rapid, point‐of‐care antigen tests for diagnosis of SARS‐CoV‐2 infection
Aspirin i slični lijekovi za liječenje duboke venske tromboze (DVT)
Liječenje iznenadnog gubitka sluha primjenom kortikosteroida u srednje uho
Koliko su točni brzi testovi za dijagnosticiranje bolesti COVID-19?
Special Collection: Achieving sustainable healthcare through deprescribing of unnecessary medications
A new Cochrane Library Special Collection provides an overview of Cochrane Reviews that summarize the potential benefits and harms of deprescribing specific medications and help to inform how to implement deprescribing across different settings and populations.
This collection of reviews highlight that deprescribing is likely feasible and safe and can lead to benefits in prescribing and clinical outcomes. However, they also highlight significant gaps in the literature and methodological challenges to both conducting deprescribing studies and systematic reviews of deprescribing.
Wednesday, July 20, 2022Utječe li vrsta anestezije za rekanalizacijsku terapiju akutnog ishemijskog moždanog udara na ishode pacijenata?
How accurate are remote, virtual assessments at diagnosing dementia?
Community views on mass drug administration for filariasis: a qualitative evidence synthesis
This week Catherine Spencer starts as Cochrane’s new Chief Executive Officer
Catherine joins Cochrane from The Seafarers’ Charity where she held the position of CEO.
Governing Board Co-Chairs, Tracey Howe and Catherine Marshall said: "We are delighted to welcome Catherine to Cochrane. Catherine is a proven Chief Executive with an exceptional record leading non-profit organisations. She brings expertise in strategic planning, change management, and communications under pinned by a global perspective. Catherine is well positioned to partner with the Editor-in-Chief, Karla Soares-Weiser, to lead Cochrane as we drive an exciting programme of delivering trusted evidence, promoting informed decisions, and better health.”
Prior to her role at The Seafarers’ Charity, Catherine was acting Chief Operating Officer and Director of Communications and Change Management at international public health research organisation, icddrb, in Dhaka, Bangladesh. Between 2008-2015 Catherine held various senior management roles at the Army Families Federation, including three years as Chief Executive.
Catherine Spencer said, “Like all organisations post-Covid, we have challenges to deal with, but I see so much opportunity for Cochrane in the future. I look forward to what will inevitably be stimulating conversations with the Cochrane Community about what a thriving future Cochrane looks like and what we need to do to achieve that as we build a long-term strategy together.
I spent three and a half years working at icddr,b, in Dhaka, Bangladesh - a large public health research organisation, that at the time was facing enormous financial and structural challenge. Working as part of the Senior Leadership Team, and very closely with the Executive Director and Board, the organization was rejuvenated, meaning its essential public health research could continue. Thus, I come to Cochrane familiar with an organisation managing change and I look forward to working with you, collaboratively to steer Cochrane to success.”
Catherine will meet with the Cochrane Community in two introductory webinars to accommodate different time zones. Invites will be sent directly to Community Members via email.
Tuesday, July 12, 2022